Zentalis Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Zentalis Pharmaceuticals, Inc. (ZNTL) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 12.26 million shares as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-03-26
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 12.26M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 13.37M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 10.02M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.05M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2025-12-31 | 12.26M shares 10-K · filed 2026-03-26 |
| 2024-12-31 | 13.37M shares 10-K · filed 2026-03-26 |
| 2023-12-31 | 10.02M shares 10-K · filed 2025-03-26 |
| 2022-12-31 | 8.05M shares 10-K · filed 2024-02-27 |
| 2021-12-31 | 4.24M shares 10-K · filed 2023-03-01 |
| 2021-03-31 | 3.80M shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 3.12M shares 10-K · filed 2022-02-24 |
| 2020-09-30 | 2.80 shares 10-Q · filed 2020-11-09 |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |